Novartis
NVS
#67
Rank
A$313.18 B
Marketcap
$156.65
Share price
0.83%
Change (1 day)
7.88%
Change (1 year)

Novartis AG is a biotechnology and pharmaceutical company based in Basel, Switzerland. Novartis was formed in 1996 from a merger of the two Basel pharmaceutical and chemical companies Ciba-Geigy AG and Sandoz AG. Novartis is one of the largest pharmaceutical companies in the world with sales of USD 47.4 billion in 2019.

Novartis (NVS) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : A$96.11 Billion

According to Novartis's latest financial reports the company's total liabilities are A$96.11 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Novartis - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31A$78.07 B-8.44%
2022-12-31A$85.27 B-3.36%
2021-12-31A$88.24 B-4.59%
2020-12-31A$92.48 B3.07%
2019-12-31A$89.72 B-5.48%
2018-12-31A$94.92 B25.92%
2017-12-31A$75.38 B-1.62%
2016-12-31A$76.62 B2.55%
2015-12-31A$74.72 B12.12%
2014-12-31A$66.64 B14.8%
2013-12-31A$58.05 B9.83%
2012-12-31A$52.85 B5.12%
2011-12-31A$50.28 B-4.62%
2010-12-31A$52.71 B24.48%
2009-12-31A$42.34 B7.24%
2008-12-31A$39.49 B32.51%
2007-12-31A$29.80 B-12.06%
2006-12-31A$33.88 B0.93%
2005-12-31A$33.57 B22.72%
2004-12-31A$27.36 B8.19%
2003-12-31A$25.28 B-14.63%
2002-12-31A$29.62 B2.52%
2001-12-31A$28.89 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
A$116.73 B 21.45%๐Ÿ‡บ๐Ÿ‡ธ USA
A$203.03 B 111.24%๐Ÿ‡บ๐Ÿ‡ธ USA
A$172.97 B 79.97%๐Ÿ‡บ๐Ÿ‡ธ USA
A$97.33 B 1.27%๐Ÿ‡ซ๐Ÿ‡ท France
A$95.47 B-0.66%๐Ÿ‡ฌ๐Ÿ‡ง UK
A$56.58 B-41.12%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
A$122.33 B 27.27%๐Ÿ‡บ๐Ÿ‡ธ USA
A$54.91 B-42.87%๐Ÿ‡บ๐Ÿ‡ธ USA
A$102.57 B 6.71%๐Ÿ‡ฌ๐Ÿ‡ง UK